For: | Mattos ÂZ, Debes JD, Vogel A, Arrese M, Revelo X, Pase THS, Manica M, Mattos AA. Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy? . World J Gastroenterol 2022; 28(28): 3595-3607 [PMID: 36161041 DOI: 10.3748/wjg.v28.i28.3595] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i28/3595.htm |
Number | Citing Articles |
1 |
Jesús Rivera-Esteban, Sergio Muñoz-Martínez, Mónica Higuera, Elena Sena, María Bermúdez-Ramos, Juan Bañares, María Martínez-Gomez, M. Serra Cusidó, Alba Jiménez-Masip, Sven M. Francque, Frank Tacke, Beatriz Minguez, Juan M. Pericàs. Phenotypes of Metabolic Dysfunction–Associated Steatotic Liver Disease–Associated Hepatocellular Carcinoma. Clinical Gastroenterology and Hepatology 2024; 22(9): 1774 doi: 10.1016/j.cgh.2024.03.028
|
2 |
Sainan Tang, Shanshan Wu, Wenzhe Zhang, Lili Ma, Li Zuo, Hua Wang. Immunology and treatments of fatty liver disease. Archives of Toxicology 2025; 99(1): 127 doi: 10.1007/s00204-024-03920-1
|
3 |
Yi Yuan, Dailin Wu, Jing Li, Dan Huang, Yan Zhao, Tianqi Gao, Zhenjie Zhuang, Ying Cui, Da-Yong Zheng, Ying Tang. Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1217400
|
4 |
Andrea del Pilar Abreo Medina, Mengdie Shi, Yanyan Wang, Zhongyu Wang, Kehe Huang, Yunhuan Liu. Exploring Extracellular Vesicles: A Novel Approach in Nonalcoholic Fatty Liver Disease. Journal of Agricultural and Food Chemistry 2025; doi: 10.1021/acs.jafc.4c09209
|
5 |
Ziwei Guo, Ziang Yao, Bohao Huang, Dongjie Wu, Yanbo Li, Xiaohan Chen, Yanping Lu, Li Wang, Wenliang Lv. MAFLD-related hepatocellular carcinoma: Exploring the potent combination of immunotherapy and molecular targeted therapy. International Immunopharmacology 2024; 140: 112821 doi: 10.1016/j.intimp.2024.112821
|